간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
항 실질 약물 시장. 2019 년에 항 간질 의약품 시장 규모는 345 억 달러로 추정되며 2022-2027 년 예측 기간 동안 CAGR 3.8%로 증가합니다. 항 간질 약물은 또한 간질 및 발작의 무증상 및 특발성 치료를 위해 개발 된 항 발작 약물로도 알려져 있습니다
Summary
Antiepileptic Drugs Market. Antiepileptic Drugs Market size in 2019 is estimated to be $ 3.45 billion, growing at a CAGR of 3.8% during the forecast period 2022-2027. Antiepileptic drug can also be known as anti-seizure drug, developed for asymptomatic and Idiopathic treatment of epilepsy and seizures
Table of Contents
1. Antiepileptic Drugs Market Overview
1.1 Definitions and Scope
2. Antiepileptic Drugs Market Executive Summary
2.1 Market Revenue, Market Size and Key Trends
2.2 Key trends by Drug Type
2.3 Key trends by Route of Administration
2.4 Key trends by Spectrum Type
2.5 Key trends by Distribution Channel
2.6 Key trends by Geography
3. Antiepileptic Drugs Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Antiepileptic Drugs Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Antiepileptic Drugs Market Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Antiepileptic Drugs Market – By Drug Type (Market Size -$Million/$Billion)
6.1 First Generation Drugs
6.1.1 Valproate (Depakote)
6.1.2 Oxycarbazepine ((Trileptal)
6.1.3 Carbamazepine (Carbatrol)
6.1.4 Phenobarbital (Luminal)
6.1.5 Primidone (Mysoline)
6.1.6 Ethosuximide (Zarontin)
6.1.7 Topiramate (Topamax)
6.2 Second Generation Drugs
6.2.1 Lamotrigine (Lamictal)
6.2.2 Pregabalin (Lyrica)
6.2.3 Eslicarbazepine acetate Zonisamide (Zonegran)
6.2.4 Lacosamide (Vimpat)
6.2.5 Levetiracetam (Keppra)
6.2.6 (Aptiom/Zebinix)
6.2.7 Perampanel (Fycompa)
6.2.8 Rufinamide (Banzel/Inovelon)
6.2.9 Ezogabine/retigabine (Trobalt/Potiga)
6.3 Pipeline Drugs
6.3.1 Buspirone
6.3.2 Everoline
6.3.3 UCB0942 (PPSI)
6.3.4 Lacosamide
6.3.5 GWP42006
6.3.6 TAK-932
6.3.7 Brivaracetam (UCB Pharma Ltd)
6.3.8 Ganaxolone (Marinus Pharmaceuticals)
6.3.9 USL261 (Upsher Smith Laboratories, Inc.)
6.3.10 Perampanel (Eisai Co)
6.3.11 YKP3089 (SK Life Sciences)
7. Antiepileptic Drugs Market– By Route of Administration (Market Size -$Million/$Billion)
7.1 Oral
7.2 Intravenous
8. Antiepileptic Drugs Market– By Spectrum Type (Market Size -$Million/$Billion)
8.1 Narrow Spectrum
8.2 Broad Spectrum
9. Antiepileptic Drugs Market– By Distribution Channel (Market Size -$Million/$Billion)
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacies
10. Antiepileptic Drugs Market- By Geography (Market Size -$Million/$Billion)
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 U.K.
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 India
10.3.5 Australia & New Zealand
10.3.6 Rest of Asia-Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Africa
10.4.3 South America
11. Antiepileptic Drugs Market Entropy
12. Antiepileptic Drugs Market Company Analysis
12.1 Company Revenue, Products, M&A, Developments
12.2 Company 1
12.3 Company 2
12.4 Company 3
12.5 Company 4
12.6 Company 5
12.7 Company 6
12.8 Company 7
12.9 Company 8
12.10 Company 9
12.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
항 실질 약물 시장. 2019 년에 항 간질 의약품 시장 규모는 345 억 달러로 추정되며 2022-2027 년 예측 기간 동안 CAGR 3.8%로 증가합니다. 항 간질 약물은 또한 간질 및 발작의 무증상 및 특발성 치료를 위해 개발 된 항 발작 약물로도 알려져 있습니다
Summary
Antiepileptic Drugs Market. Antiepileptic Drugs Market size in 2019 is estimated to be $ 3.45 billion, growing at a CAGR of 3.8% during the forecast period 2022-2027. Antiepileptic drug can also be known as anti-seizure drug, developed for asymptomatic and Idiopathic treatment of epilepsy and seizures
Table of Contents
1. Antiepileptic Drugs Market Overview
1.1 Definitions and Scope
2. Antiepileptic Drugs Market Executive Summary
2.1 Market Revenue, Market Size and Key Trends
2.2 Key trends by Drug Type
2.3 Key trends by Route of Administration
2.4 Key trends by Spectrum Type
2.5 Key trends by Distribution Channel
2.6 Key trends by Geography
3. Antiepileptic Drugs Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Antiepileptic Drugs Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Antiepileptic Drugs Market Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Antiepileptic Drugs Market – By Drug Type (Market Size -$Million/$Billion)
6.1 First Generation Drugs
6.1.1 Valproate (Depakote)
6.1.2 Oxycarbazepine ((Trileptal)
6.1.3 Carbamazepine (Carbatrol)
6.1.4 Phenobarbital (Luminal)
6.1.5 Primidone (Mysoline)
6.1.6 Ethosuximide (Zarontin)
6.1.7 Topiramate (Topamax)
6.2 Second Generation Drugs
6.2.1 Lamotrigine (Lamictal)
6.2.2 Pregabalin (Lyrica)
6.2.3 Eslicarbazepine acetate Zonisamide (Zonegran)
6.2.4 Lacosamide (Vimpat)
6.2.5 Levetiracetam (Keppra)
6.2.6 (Aptiom/Zebinix)
6.2.7 Perampanel (Fycompa)
6.2.8 Rufinamide (Banzel/Inovelon)
6.2.9 Ezogabine/retigabine (Trobalt/Potiga)
6.3 Pipeline Drugs
6.3.1 Buspirone
6.3.2 Everoline
6.3.3 UCB0942 (PPSI)
6.3.4 Lacosamide
6.3.5 GWP42006
6.3.6 TAK-932
6.3.7 Brivaracetam (UCB Pharma Ltd)
6.3.8 Ganaxolone (Marinus Pharmaceuticals)
6.3.9 USL261 (Upsher Smith Laboratories, Inc.)
6.3.10 Perampanel (Eisai Co)
6.3.11 YKP3089 (SK Life Sciences)
7. Antiepileptic Drugs Market– By Route of Administration (Market Size -$Million/$Billion)
7.1 Oral
7.2 Intravenous
8. Antiepileptic Drugs Market– By Spectrum Type (Market Size -$Million/$Billion)
8.1 Narrow Spectrum
8.2 Broad Spectrum
9. Antiepileptic Drugs Market– By Distribution Channel (Market Size -$Million/$Billion)
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacies
10. Antiepileptic Drugs Market- By Geography (Market Size -$Million/$Billion)
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 U.K.
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 India
10.3.5 Australia & New Zealand
10.3.6 Rest of Asia-Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Africa
10.4.3 South America
11. Antiepileptic Drugs Market Entropy
12. Antiepileptic Drugs Market Company Analysis
12.1 Company Revenue, Products, M&A, Developments
12.2 Company 1
12.3 Company 2
12.4 Company 3
12.5 Company 4
12.6 Company 5
12.7 Company 6
12.8 Company 7
12.9 Company 8
12.10 Company 9
12.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
